Your Location:
Home >
Browse articles >
Oral Chinese Patent Mediciens for Lung Cancer:A Scoping Review of Clinical Evidence
Oral Chinese Patent Mediciens for Lung Cancer:A Scoping Review of Clinical Evidence
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 28, Issue 8, Pages: 204-213(2022)
DOI: 10.13422/j.cnki.syfjx.20220895
Scan QR Code
Full Text(HTML)
Figs( 3 ) Tabs( 3 )
Editor's note
References
Publication Info
Metrics
423
Views
197
Downloads
4
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Clinical Researches on Chinese Patent Drug for Diabetes: A Scoping Review
Oral Chinese Patent Medicines for Breast Cancer:A Scoping Review of Clinical Evidence
A Multicenter, Double-blind,Randomized Controlled Study of Qingfei Huatan Tongqiao Formula for Treating Adenoid Hypertrophy in Children
Mechanism of Feiyanning Formula in Suppressing Invasion and Metastasis of Lung Cancer Cells via Modulating Exosomal miR-328 and STAT3/c-Fos/NFATc1 Pathway
Research on Patterns of Syndrome Differentiation and Treatment for Lung Cancer Based on Case Reports: An Evidence-based Pathway Exploration for Complementing Clinical Guidelines
Related Author
YANG Yanan
PANG Qing
CHEN Yupeng
NI Qing
LIAO Xing
MAO Li
TANG Jiang-yuan
LIAO Xing
Related Institution
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Institute of Basic Research In Clinical Medicine,China Academy of Chinese Medical Sciences
Hospital of Chengdu University of Traditional Chinese Medicine,Chengdu 6100752
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Longhua Hospital,Shanghai University of Traditional Chinese Medicine


